Interest in RNA dysfunction in amyotrophic lateral sclerosis (ALS) recently aroused upon discovering causative mutations in RNAbinding protein genes. Here, we show that extensive downregulation of miRNA levels is a common molecular denominator for multiple forms of human ALS. We further demonstrate that pathogenic ALS-causing mutations are sufficient to inhibit miRNA biogenesis at the Dicing step. Abnormalities of the stress response are involved in the pathogenesis of neurodegeneration, including ALS. Accordingly, we describe a novel mechanism for modulating microRNA biogenesis under stress, involving stress granule formation and re-organization of DICER and AGO2 protein interactions with their partners. In line with this observation, enhancing DICER activity by a small molecule, enoxacin, is beneficial for neuromuscular function in two independent ALS mouse models. Characterizing miRNA biogenesis downstream of the stress response ties seemingly disparate pathways in neurodegeneration and further suggests that DICER and miRNAs affect neuronal integrity and are possible therapeutic targets.
Introduction
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease of the human motor neuron system. Mutations in genes encoding RNA-binding proteins were recently identified as causative in human ALS. These include TAR DNA-binding protein 43 (TDP-43) (Kabashi et al, 2008; Sreedharan et al, 2008; Liu-Yesucevitz et al, 2010; McDonald et al, 2011) , fused in sarcoma (FUS) (Kwiatkowski et al, 2009; Vance et al, 2009; Bosco et al, 2010; Gal et al, 2010) and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) .
Stress granules (SGs) are cytoplasmic sites for modulating mRNA translation and form in response to cellular stress (Anderson & Kedersha, 2008 Buchan & Parker, 2009) . Intriguingly, among the RNA-binding proteins that are recruited into SGs, several are mutated in ALS or the related disorder fronto-temporal dementia (FTD), for example, TDP-43 and FUS.
Stress and SGs are thought to be involved in the pathogenesis of ALS, and SGs are observed in pathologic ALS/FTD specimen (Neumann et al, 2007; Volkening et al, 2009; Bosco et al, 2010; Dormann et al, 2010; Gal et al, 2010; Liu-Yesucevitz et al, 2010; Dewey et al, 2011; McDonald et al, 2011; Meyerowitz et al, 2011; Aulas et al, 2012; Baron et al, 2013; Daigle et al, 2013; Kim et al, 2013; Vance et al, 2013; reviewed in Dewey et al, 2012; Emde & Hornstein, 2014; Li et al, 2013b; Ling et al, 2013) . SG formation is initiated by the phosphorylation of eukaryotic translation initiation factor 2 alpha (EIF2A) on serine-51 or by the expression of several aggregation-prone proteins that are capable of initiating SG nucleation (Kedersha et al, 1999) . Accordingly, modulation of EIF2A phosphorylation mitigates neurotoxicity in animal models of ALS (Saxena et al, 2009; Kim et al, 2014) . microRNAs (miRNAs) are small endogenous RNAs. Initial processing of primary miRNAs by Drosha/Dgcr8 (Gregory et al, 2004) yields an intermediate pre-miRNA that is further processed by the 500-kDa DICER multi-protein complex to form a mature miRNA. This complex contains DICER 1, ribonuclease type III (DICER) and its partners, Argonaute RISC catalytic component 2 (AGO2), TAR (HIV-1) RNA-binding protein 2 (also known as TRBP) and protein kinase, interferon-inducible double-stranded RNAdependent activator (PACT) (Chendrimada et al, 2005; Haase et al, 2005; Lee et al, 2006) . DICER activity is controlled by its core partners Shan et al, 2008; Li et al, 2012; Lee et al, 2013) and the mature miRNA is loaded onto AGO2, creating a functional RNA-induced silencing complex (RISC).
DICER and its co-factors participate at multiple levels of the stress response (Emde & Hornstein, 2014) . Thus, DICER contributes to stress resistance in selected tissues and its deficiency reduces stress tolerance (Mori et al, 2012) . In addition, various stresssignaling cascades control AGO2 post-translational modifications, its translocation into SGs and its activity (Leung et al, 2006; Qi et al, 2008; Zeng et al, 2008; Shen et al, 2013) .
We previously demonstrated that loss of miRNA biogenesis is sufficient to cause spinal motor neuron degeneration in vivo (Haramati et al, 2010 ). In the current work, we demonstrate that reduction in miRNA levels is a common molecular denominator for multiple forms of familial and sporadic human ALS and that enhancement of DICER activity is beneficial in vivo in two independent ALS mouse models. The observations establish a novel pathway downstream of the stress response that controls DICER complex activity. The regulation of DICER involves stress granule assembly and dynamic interactions with SG proteins. This new mechanism for the control of miRNA biogenesis offers novel therapeutic targets for ALS.
Results

miRNAs are down-regulated in motor neurons of human ALS patients
We recently demonstrated that conditional inactivation of DICER in motor neurons is sufficient to cause spinal motor neuron degeneration in vivo (Haramati et al, 2010) . Additional works from other groups further suggest the involvement of miRNAs in ALS pathogenesis (Williams et al, 2009; Buratti et al, 2010; Kawahara & Mieda-Sato, 2012; Morlando et al, 2012; Droppelmann et al, 2013; Freischmidt et al, 2013; Koval et al, 2013; Zhang et al, 2013) . To pursue this, we examined miRNA expression in lumbar motor neurons of sporadic ALS (sALS) spinal cords isolated by laser capture microdissection (LCM). Global down-regulation of miRNAs was observed in motor neurons. The observation seemed specific to motor neurons since RNA extracted from surrounding, motor neuron-depleted ventral-horn tissue of sALS patients or from neurons of Clarke's column (non-motor neuron) isolated by LCM within the same nervous systems did not exhibit such global changes in miRNA expression (Fig 1A-C) . The observations of miRNA down-regulation were substantiated by miRNA in situ hybridization, which revealed down-regulation of miR-9 and miR-124 in patient tissue, relative to control tissue and to the hybridization signal of U6 RNA (Fig 1D) . We next investigated whether miRNAs display a similar profile in fALS cases. Indeed, analyzing two nervous systems carrying familial SOD1 A4V mutation, revealed similar down-regulation of miRNAs (Fig 1E and F) that correlated with miRNA changes, observed in sALS (Pearson's correlation coefficient = 0.3). Our data suggest that changes in miRNA expression, which were previously reported in ALS spinal cord extracts (Campos-Melo et al, 2013) , are primarily due to changes in miRNA expression in motor neurons. Attempts to measure pre-miRNAs in human LCM samples were unsuccessful, probably due to the low abundance of these intermediate precursors. Noteworthy, expression and splicing data for changes in mRNAs encoding miRNA biogenesis factors from the relevant ALS patients did not reveal any change, relative to controls (Rabin et al, 2009) . Additionally, 27 long ncRNAs tested were similarly expressed in another cohort of 12 non-ALS and 12 sporadic ALS nervous systems, with Pearson's correlation of 0.9882. Since miRNAs are globally down-regulated in sALS cases that are genetically unrelated, reduced miRNA expression in motor neurons appears to be a common denominator of various forms of ALS.
Cellular stress affects pre-miRNA processing
Stress pathways are thought to control miRNA activity (Leung & Sharp, 2010; Mendell & Olson, 2012; Emde & Hornstein, 2014) , but the idea that cellular stress might broadly regulate miRNA biogenesis has not been tested. We sought to do so by the measurement of the relative levels of mature miRNAs and premiRNAs under several stress conditions. We further defined an "inhibition score" that approximates a value of one, when DICER processes pre-miRNAs effectively, as in wild-type conditions, and increases >1, when miRNA biogenesis is inhibited, relative to control (Fig 2A) .
We chose representative miRNAs that are expressed in human and mouse motor neurons including miR-10b, miR-30a and miR-103 (abundantly expressed in isolated mouse motor neurons); miR-218, miR-30c, miR-138 and let-7b (highly expressed in human motor neurons); miR-132, let-7c and let-7d (neuronal, mid-range in human); and miR-143 and let-7a (low expression in human neurons).
We triggered cellular stress in the hybrid motor neuron cell line NSC-34; using thapsigargin induced markers of ER stress (Appendix Fig S1A) , down-regulated mature miRNA levels and up-regulated pre-miRNA levels, relative to control, demonstrating the inhibition of miRNA biogenesis (Fig 2B-D) . In addition, application of oxidative stressors, paraquat or sodium arsenite, led to the inhibition of miRNA biogenesis (Fig 2E-J, Appendix Fig S1B) .
To test whether changes in DICER or its co-factors are downregulated as a result of stress, we measured protein levels by Western blot analysis. The expression levels of the four DICER complex proteins were not down-regulated by two independent stressors (thapsigargin, paraquat). DICER and AGO2 levels were not reduced by sodium arsenite as well, but PACT and TRBP levels were reduced by 1/3 (Appendix Fig S2 related to Fig 2) . We conclude that alteration of DICER activity may occur even without reduction in DICER complex components.
Expression of ALS-causing genes inhibits pre-miRNA processing
To assess whether ALS-causing genes affect miRNA biogenesis similar to chemical stressors, we transfected NSC-34 cells with vectors of wild-type FUS, TDP-43 and SOD1 or mutant forms of the same genes, specifically FUS R495X (Bosco et al, 2010; Waibel et al, 2010) , TDP-43 A315T (Gitcho et al, 2008 ) and SOD1 G93A (Rosen et al, 1993) (Fig 3A) . We observed inhibition in biogenesis of many of the miRNA species tested, relative to the corresponding control sample values, after overexpression of wild-type or mutant FUS and TDP-43 (Fig 3B-E, Appendix Fig S3) . The inhibitory effect of wild-type SOD1 or G93A mutant on miRNA biogenesis was consistent with this, but more limited (Fig 3F  and G) . The deleterious effect of higher-than-normal levels of A-C Volcano plots of P-values (y-axis log 10 scale) for relative miRNA expression (x-axis log 2 scale). (A) Human lumbar motor neurons (eight sporadic ALS nervous systems, nine non-neurodegeneration controls), (B) anterior horn tissue without motor neurons from the same individuals (10 sporadic ALS nervous systems, nine controls) and (C) miRNA expression in Clarke's column (three sporadic ALS nervous systems versus three controls). D Representative micrographs with in situ hybridization for miR-9 and miR-124; scale bar indicates 10 lM. Bar graph displays signal intensity, quantified in 300 different motor neurons of two ALS nervous systems and two controls, normalized to U6 in situ hybridization signal. Error bars represent s.d. E, F miRNA expression in lumbar motor neurons of two familial ALS nervous systems versus nine controls (E) and the respective anterior horn tissue depleted of motor neurons (F). Analyses were performed as in (A-C).
Data information: (A-C, E, F) Black dots indicate P < 0.05; light gray dots are non-significant. miRNAs were measured using TaqMan array microRNA cards, normalized to the average of three control RNAs: RNU48/SNORD48, RNU44/SNORD44 and U6 and subjected to ANOVA Statistics (DataAssist, Life Technologies). Source data are available online for this figure. ª Fig S4 related to Fig 3) . A Diagram depicting the working hypothesis. The DICER complex is composed of DICER, AGO2, PACT and TRBP, and the catalysis of pre-miRNA hairpins into mature AGO2-loaded miRNAs is schematically presented by a vertical arrow. Stress inhibits Dicing, resulting in the accumulation of substrate (pre-miRNA) and reduction in product levels (mature miRNA). The ratio of substrate to product, defined as "inhibition score," approximates a value of 1 in the unmanipulated wild-type conditions. Inhibition score values greater than 1, reflect reduced DICER activity. B-J Pre-miRNA (B, E, H) and miRNA (C, F, I) expression analysis and their corresponding inhibition score (D, G, J). NSC-34 cells treated with thapsigargin (10 nM for 24 h) or control carrier (DMSO) (B-D), paraquat (25 lM for 24 h) or control carrier (water) (E-G) and sodium arsenite (0.5 mM for 60 min) or control carrier (water) (H-J). Displayed are average and standard error of the mean (s.e.m.) for qPCR analyses of at least three independent experiments, normalized to the expression levels in control treatments. Pre-miRNA levels were normalized to beta-actin and Gapdh, and miRNAs were normalized to Snord68 and Snord70. P-values of qPCR were calculated via ANOVA statistics with DataAssist, and with two-sided Student's t-test for inhibition score. Significant P-values are indicated by *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. The EMBO Journal Dysregulated miRNA biogenesis in ALS Anna Emde et al
In order to test DICER activity directly, we devised a cell-free Dicing assay, using cell lysates and synthetic double-stranded RNA, carrying a quencher on a 25-nt passenger strand and a CY3 fluorophore conjugate on a 27-nt precursor guide strand. Dicing activity enables the dissociation of a fluorophore conjugate RNA from the quencher and fluorescence (Fig 4A) . The assay demonstrated reduction in DICER catalytic activity in lysates of cells treated with sodium arsenite, paraquat or thapsigargin (Fig 4B and C) . Importantly, overexpression of ALS-causing mutants or their respective wild-type forms also reduced DICER activity (Fig 4D) e.m. of > 3 independent experiments, except for pre-miRNAs in the study of FUS R495X (n = 2). P-values were calculated by two-sided Student's t-test, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
Source data are available online for this figure. 
A
Diagram of the in vitro DICER activity assay, in which an annealed double-stranded RNA substrate is composed of a fluorophore-conjugated 27-nt guide strand and a 25-nt passenger strand conjugated to a quencher moiety. The DICER complex releases a 21-nt mature single-stranded guide RNA, whose fluorescence correlates with DICER activity. B, C Dicing in vitro assay was performed in NSC-34 lysates after treatment with (B) sodium arsenite (0.5 mM for 60 min), paraquat (25 lM for 24 h) or control carrier (water), or alternatively (C) with thapsigargin (10 nM for 24 Data information: (B-G) Shown are average and s.e.m. of > 3 independent experiments. P-values were calculated by two-sided Student's t-test, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Source data are available online for this figure.
The The EMBO Journal Dysregulated miRNA biogenesis in ALS Anna Emde et al DICER cofactors in the reaction buffers. Therefore, overexpression of ALS genes, mutation in ALS genes and the application of oxidative or ER stress all inhibit DICER catalytic activity.
Enoxacin ameliorates ALS-induced defects in pre-miRNA processing
Next, we hypothesized that enhancing Dicing complex activity might reverse the negative effect of the ALS-causing mutant proteins on miRNA processing. We tested this hypothesis by employing enoxacin, a fluoroquinolone antibiotic that is commonly used for the treatment of urinary tract and airway infections. Enoxacin is known to increase miRNA biogenesis via increasing the binding affinity of TRBP and pre-miRNAs (Shan et al, 2008; Melo et al, 2011) . Intriguingly, the impairments in pre-miRNA processing that were evident in NSC-34 cells upon transfection with vectors expressing ALS-causing mutants FUS R495X, TDP-43 A315T or SOD1 G93A were partially ameliorated by applying enoxacin (100 lM for 72 h) to transfected cultures . Therefore, enoxacin studies further support the view that DICER activity is impaired in culture models of ALS.
Stress granule formation controls miRNA biogenesis
To gain further mechanistic insight, we performed targeted mass spectrometry analysis of AGO2 and DICER protein interactions under cellular stress ( Fig 5A) . We examined a set of proteins that were co-immunoprecipitated with either AGO2 or DICER in a preliminary unbiased screen. Targeted mass spectrometry revealed enhanced interactions of AGO2 with DICER in cells that were treated with sodium arsenite, relative to basal conditions ( Fig 5B and C) . We report increased AGO2 binding to DICER, which was previously shown to decrease DICER complex activity (Tahbaz et al, 2004) . As DICER complex composition controls miRNA biogenesis (Lee & Doudna, 2012; Lee et al, 2013) , we measured additional AGO2 and DICER interactions. HSP90 and co-chaperone p23, which regulate the interactions of DICER with AGO2 (Tahbaz et al, 2004; Pare et al, 2013) , increased their interactions with DICER under stress ( Fig 5B) . These interactions potentially stabilize an intermediate DICER-AGO2-P23-HSP90 complex (Pare et al, 2013) , thereby inhibiting DICER catalytic activity. In addition, cellular stress increased AGO2 and/or DICER protein interactions with SG components EIF2A, EIF3 (Kedersha et al, 2005) and EIF5A (Li et al, 2010) and with poly(rC)-binding proteins PCBP1 (hnRNP E1) and PCBP2 (hnRNP E2) (Li et al, 2012) (Fig 5B and C) . PCBPs are iron chaperones Nandal et al, 2011) , found in SGs and P-bodies (Fujimura et al, 2008 (Fujimura et al, , 2009 . PCBP2 binds to miRNA precursors and presents them to DICER for efficient processing (Li et al, 2012) . Therefore, the binding of PCBP1 and 2 to AGO2 and DICER exposes an additional layer of complexity in the regulation of miRNA biogenesis under stress.
Finally, AGO2 is phosphorylated by the p38 mitogen-activated protein kinase on serine-378 under stress (Zeng et al, 2008) , consistent with a > 10-fold increase in AGO2 serine-387 phosphorylation in our system ( Fig 5C) . Intriguingly, p38 was reported to be persistently activated in ALS (Tortarolo et al, 2003) . We further validated increased interactions of AGO2 with PCBP1, by AGO2 immunoprecipitation and Western blot analysis. DICER pull-down was marginally significant, and we could not validate the increased interaction of PACT with AGO2 ( Fig 5D) .
Taken together, these observations point toward substantial changes in the interactions of DICER and AGO2 with SG components. Next, we tested the hypothesis that SG formation may be sufficient to attenuate DICER complex activity. We overexpressed TIAR, a known initiator of stress granule formation (Kedersha et al, 1999) , which reduced DICER catalytic activity in a cell-free assay (Fig 5E) . EIF5A is a translation elongation factor, which is engaged with SGs under stress (Li et al, 2010) and also with DICER ( Fig 5B) . We demonstrated that EIF5A overexpression reduced DICER catalytic activity in a cell-free assay and in cells (Fig 5E and F and Appendix Fig S6A and B) .
Several cellular stress-signaling cascades converge into the phosphorylation of Serine-51 of the translation initiation factor 2 alpha (EIF2A), thereby driving SG formation (Hinnebusch, 2005; Kedersha et al, 2005) . Because EIF2A interactions with AGO2 and/or DICER increased by stress (Fig 5B and C) , we tested the implications of overexpressing a phosphomimetic version of EIF2A (S51D). Expression of EIF2A S51D resulted in inhibition of DICER activity (Fig 5G and Appendix Fig S6C and D) , further linking stress signaling to reduced miRNA biogenesis. Accordingly, phosphorylation-resistant serine-to-alanine-mutated EIF2A (S51A) (Costa-Mattioli et al, 2007) enabled a partial recovery from thapsigargin-induced attenuation of DICER complex activity in mouse embryonic fibroblasts (Appendix Fig S7 related to Fig 5) .
To test whether the experimental manipulations we used are sufficient to induce visible SGs, we utilized immunofluorescence microscopy. This study revealed the onset of TIA1-positive stress granules with a set of chemical SG inducers, or after transient transfection with vectors expressing wild-type or mutant forms of FUS, TDP-43 or SOD1. It may be that high plasmid copy number and the stress of the transient transfection contributed to the induction of SGs by wild-type FUS, which was not reported in a stably transfected cell line (Bosco et al, 2010; Dormann et al, 2010; Daigle et al, 2013) .
In addition, overexpression of SG proteins that were sufficient to inhibit DICER activity, EIF5A, EIF2A S51D or TIAR led to the formation of TIA1-positive SGs (Fig 6) . Intriguingly, under all these conditions, AGO2 was co-localized with TIA1 in SGs, in accordance with the previous reports that observed AGO2 recruitment into SGs (Leung et al, 2006; Wu et al, 2011) . Therefore, interactions of SG proteins with AGO2 and/or DICER directly contribute to the attenuation of DICER activity.
We next tested the effect of SGs on DICER activity via chemical induction or blockade of SG formation (Fig 7A) . NSC-34 cells were treated with puromycin (1 lg/ml, 24 h), which drives dismantling of translating polysomes, thereby inducing SGs (Blobel & Sabatini, 1971) . Puromycin decreased the efficacy of miRNA biogenesis in a cell-free Dicing assay (Fig 7B) and in cells, as measured by qPCR ( Fig 7C and Appendix Fig S8A and B) . Notably, puromycin (1 lg/ml, 24 h) reduced DICER and TRBP levels by 44 and 31%, respectively (Appendix Fig S9A and B related to Fig 7) . Because the interpretation of the puromycin experiment can take into consideration reduction in DICER/TRBP levels, we sought a complementary approach to test whether inhibition of SG formation recovers miRNA biogenesis from ALS mutant-induced Dicing defects. Cycloheximide (CHX) is known to dissolve pre-formed SGs (Kedersha et al, 2000) . A Diagram depicting the working hypothesis that DICER complex interactions with stress granule proteins is modified by chemical stressors, overexpression of phosphomimetic EIF2A or overexpression of stress granule proteins. B, C Targeted mass spectrometry analysis of proteins, co-immunoprecipitated with DICER-FLAG (B) or AGO2-FLAG (C), from HEK293 cells treated with sodium arsenite (0.5 mM, 60 min). Data are presented as ratio of averaged peptide counts from three different peptide standards per protein, relative to peptide levels in untreated cells. Note that two peptides were identified above threshold for EIF5A and for TRBP in the AGO2-IP, and AGO2 phospho-S387 is measured by a single peptide. Averages AE s.e.m.; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 by two-sided Student's t-test, between arsenite and control treatment are denoted. D Western blot study and densitometry of DICER, AGO2, PCBP1 and PACT after AGO2-FLAG immunoprecipitation, in three different biological replicates without or with sodium arsenite (0.5 mM, 60 min). Averages AE s.e.m.; two-sided Student 0 s t-test, ***P < 0.001, for changes in AGO2 co-immunoprecipitated protein levels.
E
In vitro Dicing activity assay in HEK293 cell lysate 72 h post-transfection with EIF5A or TIAR. Averages AE s.e.m.; ****P < 0.0001 by two-sided Student's t-test from > 3 independent biological replicates. Fig S8C-H) and reduced the abundance of visible SG that were quantified by confocal microscopy (Fig 7G and H) . Noteworthy, it is unlikely that the effect of CHX was due to a general inhibition of protein synthesis since puromycin, which equally inhibits translation, had an opposite effect (Fig 7B) . Furthermore, with the CHX concentrations we used, we did not see a reduction in the ectopic expression of FLAG-TDP-43 A315T or GFP-FUS R495X and CHX was unable to affect miRNA levels when applied to untransfected NSC-34 cells (Appendix Fig S10A- C, related to Fig 7) .
miRNAs down-regulation in the SOD1 G93A mouse model of ALS is reversed by enoxacin
We next extended our observations to the SOD1 G93A mouse model of ALS (B6SJL-Tg (SOD1*G93A)1Gur/J mouse strain) (Gurney et al, 1994) . We detected down-regulation of several miRNAs in SOD1 G93A spinal cords at day 137, relative to the expression of the same miRNAs at day 77. These changes were not observed in age-matched and litter-matched wild-type controls (Appendix Fig S11A related to Fig 8) . The mRNA and protein levels of AGO2, DICER, PACT and TRBP remained unchanged (Appendix Fig S11B and C related to  Fig 8) . The relatively mild reduction may be due to extracting RNA from the whole spinal cord tissue. Recently, enoxacin was shown to increase the expression of miRNAs in the frontal cortex of rats with beneficial impact on depression (Smalheiser et al, 2014 ). Therefore, we tested whether miRNA levels are changed in vivo after oral application of enoxacin (n = 5) or carrier (water, n = 5) to SOD1 G93A male siblingmatched cohorts. Treatment starting on day 42 of the mouse life did not affect miRNA levels in wild-type motor cortices that were harvested at day 90, relative to controls. However, the levels of several miRNAs were up-regulated by enoxacin in SOD1 G93A motor cortices (Appendix Fig S11D and E related to Fig 8) .
Enoxacin therapy is beneficial for neuromuscular function in the SOD1 G93A mouse model of ALS We next tested whether enoxacin has a beneficial effect on neuromuscular function of SOD1 G93A mice (Gurney et al, 1994) . We observed a~7-day delay at the onset of neurological symptoms of the enoxacin-treated group (n = 40) relative to sibling-matched male cohort treated with carrier (water, n = 37) (Fig 8A) . Consistently, weight peak and onset of weight decline, which is defined by the loss of 1 g bodyweight after the weight peak, were delayed in enoxacintreated mice (Fig 8B and C) . Kaplan-Meier survival analysis did not yield significant differences between the two groups (Fig 8D) . However, evaluation of neurological status by employing a common neurological scoring system, with numerical values increasing from 0 to 4 as the disease progresses (Gill et al, 2009) . Neurological scoring revealed that the enoxacin-treated cohort was superior to untreated controls (Fig 8E) .
To further evaluate motor function, we performed automated quantitative gait analysis, using the CatWalk system (Neumann et al, 2009 ). Swing speed was significantly higher and stride length was significantly increased in the enoxacin-treated group, relative to untreated controls (ten matched siblings per group, Fig 8F and G) . Additionally, the performance of the enoxacin-treated group was superior to untreated siblings in a rotarod test (n = 25 control, n = 29 enoxacin, Fig 8H) . Therefore, enoxacin has a beneficial effect on multiple clinical parameters of the SOD1 G93A mouse model. Furthermore, even a lower enoxacin dose significantly improved gross strength on a hang-wire assay and the clinical neurological score, relative to controls (16 animals treated with enoxacin, 15 untreated controls; Fig 8I and J) . Finally, enoxacintreated animals (n = 6) moved significantly more than untreated controls (n = 5) in a fully automated infrared-based home cage locomotion assay (Fig 8K) . Although enoxacin did not extend the lifespan of the SOD1 G93A model, an array of different assays revealed improved neuromuscular function, suggesting a beneficial profile. Noteworthy, riluzole, the only FDA-approved drug for ALS, lacks survival benefit in SOD1G93A mice (Scott et al, 2008; Li et al, 2013a) . Therefore, as previously suggested (Scott et al, 2008) , the predictive value of the aggressive SOD1 G93A model may be limited due to its 23 transgene copies in testing novel pharmacological interventions.
We also tested enoxacin in the TDP-43 A315T transgene (Wegorzewska et al, 2009 ). Enoxacin-treated TDP-43 A315T females displayed an improved neurological score, relative to a control cohort (nine treated animals, eight untreated controls; treatment started on day 42; Fig 8L) , performed better on the Hangwire test (Fig 8M) and displayed improved stride length (Fig 8N) . Of note, characterization of the TDP-43 A315T mice was performed until the onset of clinical gastro-intestinal pathology, which leads to early death of this TDP-43 A315T mouse line and precludes the full development of ALS (Esmaeili et al, 2013) .
Discussion miRNAs function at an intriguing interface of cellular stress and disease (Leung & Sharp, 2007; Mendell & Olson, 2012; Emde & Hornstein, 2014) . Accordingly, facets of miRNA malfunction in ALS or frontotemporal dementia were reported in the past: We demonstrated that loss of DICER is sufficient to cause progressive degeneration of spinal motor neurons (Haramati et al, 2010) . In addition, specific miRNA genes are involved in feedback loops upstream or downstream of FUS (Morlando et al, 2012; Dini Modigliani et al, 2014) or TDP-43 (Buratti et al, 2010; Kawahara & Mieda-Sato, 2012) . miRNAs were suggested to regulate neuromuscular junction repair (Williams et al, 2009; Valdez et al, 2014) , to plausibly regulate neuro-inflammation in ALS (Koval et al, 2013) and may serve as circulating biomarkers (De Felice et al, 2014; reviewed in Droppelmann et al, 2014; .
The current work provides novel evidence that global downregulation of miRNAs is a molecular commonality for genetically unrelated forms of human ALS and suggests that similar previous observations (Campos -Melo et al, 2013) are primarily due to changes in miRNA expression in motor neurons.
The observations in human samples led us to investigate the mechanism. We demonstrated that decreased DICER catalytic activity is reducing miRNA levels. Several lines of evidence suggest that DICER complex activity is inhibited by the emergence of SGs: (i) The interaction of several RNA-binding proteins that are normally 
A
Diagram depicting the working hypothesis that DICER complex activity is attenuated by stress granules that can be initiated by polysome disassembly. Inhibition of DICER activity by overexpression of ALS-causing proteins can be mitigated by inhibiting stress granule formation with cycloheximide or by enhancing DICER activity with enoxacin. B Dicing in vitro assay was performed on lysates of NSC-34 cells, treated with puromycin (1 lg/ml for 24 h) or carrier (water). Average values of > 4 independent biological repeats; error bars represent s.e.m.; ***P < 0.001 by two-sided Student's t-test. C-F Inhibition score of individual pre-miRNA:miRNA pairs in NSC-34 cells treated with puromycin (1 lg/ml for 24 h) or carrier (water) (C) or cells transfected with ALScausing FUS R495X (D), TDP-43 A315T (E) or SOD1 G93A (F) or control vector and treated with low-dose cycloheximide (CHX) (0.02 lg/ml) or carrier (water), starting at 6 h post-transfection. Cells were harvested 72 h post-transfection. Calculated values are based on qPCR analysis of pre-miRNAs and mature miRNAs presented in Appendix Fig S8. Inhibition score was normalized to values in cells transfected with control vector. Averages AE s.e.m.; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 by two-sided Student's t-test from > 3 independent biological replicates. A-H Oral application of enoxacin (800 mg/kg bodyweight/day, n = 40) or carrier (water; n = 37) to SOD1 G93A male mice started on day 42 of the mouse life.
(A) Onset of symptoms (neurological score 1); log-rank Mantel-Cox test, **P = 0.0025. (B) Weight peak, log-rank Mantel-Cox test, ***P = 0.0002. (C) Onset of weight decline, defined as the loss of 1 g bodyweight after the weight peak were measured; log-rank Mantel-Cox test, **P = 0.0099. (D) Kaplan-Meier survival plot reveals comparable life span of SOD1 G93A mice, regardless of therapy. Not significant (n.s.), by log-rank Mantel-Cox test. (E) Average neurological score, which increases with disease progression, per cohort (n = 40 enoxacin-treated, n = 37 controls), two-way ANOVA test, ****P < 0.0001 (control versus enoxacin). Post hoc Holm-Sidak tests did not reveal significant differences comparing control versus enoxacin at single time points. (F, G) Fully automated gait CatWalk analysis with ten matched siblings per group. (F) Four-paw swing speed on day 73, two-way ANOVA *P = 0.027 (control versus enoxacin). (G) Four-paw stride length on day 80, two-way ANOVA *P = 0.012 (control versus enoxacin). Post hoc Holm-Sidak tests did not reveal significant differences when comparing single-paw behavior.
(H) Multiple time point rotarod performance, normalized to initial performance at day 92 of each individual (n = 25 control, n = 29 enoxacin). Two-way ANOVA with repeated measures for each individual, *P = 0.047 (control versus enoxacin), followed by post hoc Holm-Sidak tests, *P < 0.05, ***P < 0.001, ****P < 0.0001. I-K Oral application of enoxacin 200 mg/kg bodyweight/day or carrier (water) to SOD1 G93A male mice started day 42 of the mouse life. (I) Hang-wire assay (n = 15 control, n = 16 enoxacin), two-way ANOVA (control versus enoxacin) **P = 0.0027, followed by post hoc Holm-Sidak tests of different time points within groups, **P < 0.001, ****P < 0.0001. Lower hang-wire score indicate greater strength. (J) Neurological score, which increases with disease progression (n = 15 control, n = 16 enoxacin), two-way ANOVA (control versus enoxacin) **P = 0.0084, followed by post hoc Holm-Sidak test reveals a significant difference at 20 weeks of age **P < 0.01. (K) Fully automated infrared-based home cage locomotion analysis (InfraMot, TSE-Systems) at 30-min intervals over a period of 46 h, days 129-130 (n = 5 control, n = 6 enoxacin). Two-way ANOVA (control versus enoxacin), ***P = 0.0004. L-N Oral application of enoxacin 200 mg/kg bodyweight/day (n = 9) or carrier (water; n = 8) to TDP-43 A315T females started at day 42 of the mouse life. (L) Onset of symptoms (neurological score 1); two-way ANOVA (control versus enoxacin) **P = 0.0013, followed by post hoc Holm-Sidak tests reveals ***P < 0.001 at day 84.
(M) Hang-wire assay, two-way ANOVA (control versus enoxacin), **P = 0.0079, followed by post hoc Holm-Sidak tests of different time points within groups, with *P < 0.05. Lower hang-wire scores indicate greater strength. (N) CatWalk analysis revealed better performance, as assessed by four-paw stride length on day 83, two-way ANOVA (*P = 0.045). Post hoc Holm-Sidak tests did not reveal significances comparing single-paw behavior. The EMBO Journal Dysregulated miRNA biogenesis in ALS Anna Emde et al found in stress granules with DICER or AGO2 increases upon stress.
(ii) Initiating SGs by overexpressing EIF5A or TIAR, the phosphomimetic form EIF2A, or by puromycin, was sufficient to reduce DICER activity in cells and in cell lysates. (iii) AGO2, a cofactor of DICER, co-localizes with TIA1 in cytoplasmic SGs after transfection of ALS-causing genes. (iv) Blocking SGs with cycloheximide or with non-phosphorylatable serine-to-alanine 51 mutant of EIF2A reversed the negative effect of ALS-causing mutants on miRNA biogenesis. Puromycin and cycloheximide are two inhibitors of translation, yet they display opposite effects both on pre-miRNA processing and, respectively, on SG formation. Thus, the protective activity of cycloheximide in motor neurons (Yang et al, 2013) is consistent with its ability to inhibit SG formation and to improve miRNA biogenesis. (v) These observations are in line with the previous identification of TDP-43 and FUS in SGs and with the fact that TDP-43 binds DICER and AGO2 directly (Kawahara & Mieda-Sato, 2012) , providing a conceivable explanation also for the stronger molecular phenotypes observed with TDP-43 and FUS, relative to SOD1. Therefore, we suggest that stress and SG formation initiate dynamic changes in DICER interactions with its co-factors, in a way that diminishes DICER complex activity. This may be because of acquired or lost interactions under stress and may be related to AGO2 post-translational modifications (Leung et al, 2006; Qi et al, 2008; Zeng et al, 2008; Shen et al, 2013) or to increased AGO2 binding to DICER, which counter-intuitively decreases DICER activity (Tahbaz et al, 2004) .
Enoxacin increases the binding affinity of TRBP to pre-miRNAs, thereby augmenting pre-miRNA processing (Shan et al, 2008; Melo et al, 2011) . We demonstrated that impaired miRNA biogenesis is mitigated by enoxacin with beneficial clinical outcome on the neuromuscular performance of two different ALS mouse models. We did not observe any lifespan extension, but also Riluzole, the only FDAapproved drug for ALS, lacks survival benefit in SOD1 G93A mice (Scott et al, 2008; Li et al, 2013a) . Therefore, as previously suggested (Scott et al, 2008) , the predictive value of the aggressive SOD1 G93A model may be limited in testing novel pharmacological interventions. Furthermore, SOD1 effect on DICER activity may be more limited than the effects mediated by FUS or TDP-43, which are RNA-binding proteins that are directly engaged in SGs.
Nonetheless, if DICER and miRNAs are indeed instrumental in the pathogenesis of ALS in humans, as we suggest, these observations hold promise for future intervention by validating DICER as a new therapeutic target. Furthermore, enoxacin is a particularly intriguing candidate for clinical assessment, based on its established safety and pharmacokinetic profile and because several forms of ALS converge in the down-regulation of miRNAs. However, more effective DICER agonists might exhibit more dramatic beneficial effects in ALS in the future. miRNAs impart robustness to cellular programs in development and in the adult life (Hornstein & Shomron, 2006; Pelaez & Carthew, 2012; Cassidy et al, 2013; Emde & Hornstein, 2014) . Accordingly, even moderate DICER and miRNA insufficiency contributes to failed homeostatic mechanisms, allowing the activation of myriad aberrant pathways that were otherwise repressed under normal miRNA activity. The consequences may contribute particularly to diminished stress resistance, creating a vicious cycle, which further increases neuronal stress up to the threshold of malfunction and death. Accordingly, in one example, even mild but long-term downregulation of brain-enriched miR-124 affected AMPA expression and frontotemporal dementia phenotype .
The sensitivity of DICER activity to cellular stress is not limited to motor neurons and may be probably relevant to other tissues under chronic stress, where decrease in miRNA or DICER abundance was reported (Kaneko et al, 2011; Mori et al, 2012; Inukai & Slack, 2013; Nidadavolu et al, 2013) . Thus, evaluating whether stress impinges on DICER activity in other disease states will be valuable. The variability in miRNA biogenesis with different stressors or by using different cell types suggests additional factors that are currently unknown.
In summary, we provide evidence for the control of miRNA biogenesis at the level of DICER complex activity, by several stressrelated cellular changes. The consecutive reduction in miRNA levels unifies various forms of ALS, suggesting that the development of novel therapies might focus on DICER or miRNAs as common critical effectors of neuronal integrity.
Materials and Methods
Human tissue miRNA analysis
Human nervous tissues were acquired by way of an Investigational Review Board and Health Insurance Portability and Accountability Act compliant process. Sporadic ALS nervous systems were from patients who had met El Escorial criteria for definite ALS. Informed consent was obtained from all subjects. Tissue measurements were carried out post-mortem and conformed to the WMA Declaration of Helsinki and the Department of Health and Human Services Belmont Report. Sporadic ALS nervous systems were from patients who had bulbar or arm-onset disease and caudal progression, and thus, the lumbar regions had relatively abundant residual motor neurons. Tissue collections were as previously described: Completed within 4-6 h of death, the motor system was dissected, embedded in OCT and stored at À80°C. RNA quality was assessed using microelectrophoresis on an Agilent 2100 Bioanalyzer as previously described. Microdissected cell punches were captured on CapSure TM Macro LCM Caps (Arcturus Bioscience). 35 to 50 cryosections were cut at a thickness of 9 lm in a À18°C cryotome and placed onto uncharged glass slides. The sections were returned to À80°C for a minimum of 3 h. They were stained with cresyl violet acetate in a 10-step, timed, nuclease-free immersion process. Motor neurons were microdissected using a Pixcell IIe Laser Capture Microdissection (LCM) System (Arcturus Bioscience) and CapSureTM Macro LCM Caps (Applied Biosystems). Each LCM session collected 500-1,000 motor neuron punches and lasted < 2.5 h. Total RNA was isolated using the RNAqueous Micro kit (Life Technologies) as per the manufacturer's procedure. RNA quality was assessed by spectrophotometric analysis using a Nanodrop ND-1000 spectrophotometer and an Agilent 2100 Bioanalyzer. Expression of 667 microRNAs was assessed using the microRNA TaqMan â qPCR Megaplex pools array on an ABI 7900HT Fast RealTime PCR System (Life Technologies). Technical replicates were run after pre-amplification using the manufacturer's protocol. Relative quantification was calculated by comparing arithmetic mean of three small RNA control genes nucleolar RNU48/SNORD48, Table EV1 and additional premiRNA sequences are from Jiang et al (2005) .
Cell-free dicing assay
Dicing assay is described in Melo and Melo (2014) with the following modifications: dsRNA substrate for measuring DICER activity was annealed from 5 0 Phos/mCmU rCmArU mUrUrC rCrUrG mGrUmA rUmGrA mCrArA rCrGrA mAmU/3 0 IABkFQ and 5 0 Cy3/ mAmU mUrCrG rUrUrG mUrCmA rUmArC rCrArG rGrArA rArUmG rAmGmC rU (Integrated DNA Technologies). Cells were lysed via sonication in hypotonic solution, with consecutive DICER assay reaction assembly by mixing 3 ll of 10× Buffer K (200 mM Hepes-KOH, pH 7.0, 20 mM dithiothreitol (DTT), 20 mM MgCl 2 ); 3 ll of 10 mM ATP; 1.5 ll of 0.5 M, freshly dissolved, creatine phosphate; 0.9 ll of 1 mg/ml creatine phosphate kinase; 0.6 ll of ribonuclease inhibitor (40 units/ll); 3 ll of labeled dsRNA (50 nM); and 18 ll of cell extract. DICER assay mix was incubated at 30°C for 2 h and diluted with 100 ll of ultra-pure water, and then, 10 ll was transferred to 384-multiwell plate (10 technical repeats for each reaction) and measured on PHERAstar FS microplate reader (BMG Labtech). Pre-annealed ssRNA Cy3 fluorescent oligo served as positive control for calibration curve. Annealed and quenched dsRNA without cell extract served as negative control for quantification of background fluorescence.
Western blot analysis
Cell extracts or immune-purified proteins were eluted by boiling in X5 sample buffer (60 mM Tris-HCl pH 6.8, 25% glycerol, 2% SDS, 14.4 mM b-mercaptoethanol, 0.1% bromophenol blue) for 5 min. The samples were separated via 8% SDS-polyacrylamide gel electrophoresis at 120 V for 70 min, electro-transferred onto nitrocellulose membrane (Whatmann, 10401383) at 100 V for 1 h, stained with Ponceau (Sigma, P7170) to asses transfer quality and then blocked for 1 h at room temperature with 5% milk protein in PBS + 0.05% Tween-20 (0.05% PBST). Blocked membranes were then incubated with shaking at 4°C overnight with primary antibodies in 5% bovine serum albumin, 0.02% sodium azide and five drops of phenol red in 0.05% PBST. Membranes were next washed 3 times for 5 min at room temperature with 0.05% PBST and then incubated with horseradish peroxidase-conjugated species-specific secondary antibodies in 5% milk for 1 h at room temperature. Membranes were washed three times for 5 min in 0.05% PBST and visualized by ImageQuant TM LAS 4000 (GE Healthcare Life Sciences) using EZ-ECL Chemiluminescence detection kit (Biological Industries, 20-500-120). Primary antibodies used are as follows: anti-DICER (ab13502) 1:500; anti-AGO2 (ab32381) 1:500; anti-PACT (ab75749) 1:1,000; anti-TRBP (ab42018) 1:1,000; anti-PCBP1 (ab74793) 1:1,000 from Abcam; anti-GAPDH (Ambion, AM4300) 1:4,000; anti-phospho-eIF2a (Ser51) (Cat# 04-342EMD, Millipore) 1:500; anti-eIF2a (sc-11386, Santa Cruz Biotechnology) 1:200; anti-TLS/FUS (cat. 611385, BD Transduction Laboratories) 1:500; and anti-TDP-43 (10782-2-AP, Proteintech) 1:1,000.
Mass spectrometry
For mass spectrometry, HEK293 cells that stably express AGO2-FLAG (n = 3 for each group) or DICER-FLAG-transfected cells (48 h posttransfection, n = 4 for each group) were untreated or stressed with 0.5 mM sodium arsenite for 60 min before harvest. IP was performed with the FLAG-IPT1 Kit (Sigma-Aldrich). Negative controls were HEK293 cells not containing a FLAG construct. Eluted proteins and the FLAG peptide were filtered using 3-kDa molecular weight cutoff spin columns (Amicon, Millipore). Buffer was exchanged to 50 mM ammonium bicarbonate (Sigma-Aldrich) in the same step. Proteins were reduced by addition of dithiothreitol (Sigma-Aldrich) to a final concentration of 5 mM and incubation for 30 min at 60°C and ULC/MS grade solvents were used for all chromatographic steps. Each sample was loaded using split-less nano-ultra-performance liquid chromatography (10k psi nanoAcquity; Waters, Milford, MA, USA). Mobile phase was as follows: A) H 2 O + 0.1% formic acid and B) acetonitrile + 0.1% formic acid. Desalting of samples was performed online using a reverse-phase C18 trapping column (180 lm i.d., 20 mm length, 5 lm particle size; Waters). The peptides in samples were separated using a C18 T3 HSS nano-column (75 lm i.d., 250 mm length, 1.8 lm particle size; Waters) at 0.3 ll/ min. Peptides were eluted from the column and into the mass spectrometer using the following gradient: 3-30% B in 90 min, 30-35% in 10 min, 35-90% B in 5 min, maintained at 90% for 5 min and then back to initial conditions. The analytical column was coupled with a quadruple orbitrap mass spectrometer (Q Exactive, Thermo Scientific), via a nano-ESI interface. Parallel reaction monitoring of mass spectrometry (MS) was according to Peterson et al (2012) at maximum injection time of 300 ms, resolution of 35,000 and target automatic gain control (AGC) of 2e5. Samples were analyzed in a random order, measuring the light and heavy forms of each target peptide. Data were processed with Skyline software (MacLean et al, 2010) . Extracted ion chromatograms were integrated, and the ratio of the light to heavy forms was calculated. Student's t-test was used, after logarithmic transformation, for statistical calculations of the differential peptide expression. Peptide sequences for mass spectrometry are described in Table EV1 .
Immunocytofluorescence microscopy
Wild-type or stably transfected AGO2-FLAG HEK293 cells were cultured on poly-A-lysin-coated coverslips and further subjected to transfection or treated with stress-inducing chemicals. For microscopy, cells on coverslips were rinsed with PBS, fixed with 4% formaldehyde, permeabilized with 0.1% Triton X-100 (SigmaAldrich, St. Louis, MO), blocked with PBS, 2% BSA and incubated with anti-TIA1 antibody (sc-1757, Santa Cruz Biotechnology), antiFlag antibody (F1804, Sigma-Aldrich) and anti-AGO2 (ab32381, Abcam) overnight. Coverslips were washed three times with PBS and incubated with secondary antibodies (Cy2 donkey anti-goat 705-495-147 and Cy5 donkey anti-mouse 715-175-150, Jackson Immunoresearch) for 1 h. Coverslips were washed 3 times with PBS, mounted with Fluoroshield TM with DAPI (F6057, Sigma) and captured with a LSM 710 confocal microscope (Carl Zeiss AG).
In vivo enoxacin study
All experiments were performed according to Weizmann Institute of Science guidelines and IACUC approval (protocol No. 03040512-1). Mice, B6SJL-Tg(SOD1*G93A)1Gur/J, which were first reported in Gurney et al (1994) , carry a hemizygous high transgene copy number of the SOD1 G93A mutant on a B6SJL hybrid background (Jackson Laboratories, 002726). The TDP-43 A315T mouse line (Wegorzewska et al, 2009 ) was on a C57BL/6J background (Jackson Laboratories, 010700). All experiments were performed siblingmatched, except the mice in the 200 mg/kg bodyweight SOD1 G93A enoxacin group, in which mice were randomly assigned to treatment groups. Animals were group-housed on a 12-h light-dark cycle. Food and water were provided ad libitum. Food pellets at cage floor, long sipper tubes on bottles and nutrient gel were used to ease accessibility to nutrition when mice deteriorated according to Gill et al (2009) . RotaRod TM performance (San Diego Instruments) was evaluated at ramp speed 4, 40 rpm. Data are presented as the average latency to fall off the rotarod of three independent rounds per time point and are normalized to average initial performance at pre-symptomatic stage for each individual for each time point. A fully automated gait analysis with the CatWalk XT TM (Noldus) system was performed. Data were obtained of > 4 independent rounds on the apparatus. For hang-wire muscle strength assessment, mice were allowed forelimb grip onto a 2-mm-thick horizontal metal wire, suspended 80 cm above surface. Ability to successfully raise hindlimbs to grip the wire and crawling to the end of the wire was scored: 1 = successful four-paw grip and crawling to the end of the wire within < 60 s; 2 = four-paw grip for > 15 s without crawling; 3 = failure to successfully establish hindlimb grip in 60 s; and 4 = inability to sustain forelimb grip for 60 s. Each mouse was evaluated in two sessions on two consecutive days, consisting of three trials each, with a 15-min inter-trial interval. The second day was used to obtain the data as displayed. Neurological score was assessed according to Gill et al (2009) : 0 = > 2 s extension of hindlimbs away from lateral midline when mouse is suspended by its tail 2-3 times; 1 = collapse or partial leg collapse toward midline or hind leg trembling during tail suspension; 2 = toes curl under at least twice during a 12-inch walk, or any part of foot is dragging along cage/table bottom; 3 = rigid paralysis or minimal joint movement, foot not being used for forward motion; and 4 = humane endpoint, mouse cannot right itself within 30 s on either side. The locomotion of animals was quantified over a period of 46 h in the home cage, by automated sensing of body-heat image using an InfraMot (TSE-Systems). Individual animal movements were summed up every 30 min. Animal statistics: rotarod performance was evaluated using the two-way ANOVA with repeated measures for each individual and post hoc Sidak-Holm tests. Weight peak, weight decline, onset of symptoms and survival were calculated with log-rank (Mantel-Cox) test. All other tests employed two-way ANOVA with post hoc Sidak-Holm tests. All animal statistics were calculated with GraphPad Prism 6 statistics program.
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